Navigation Links
Zassi Medical Evolutions Launches New Online Company That Uses 'Business DNA' to Deliver Advanced Discovery, Collaboration, and Business Intelligence Tools to the Medical Device Industry
Date:1/13/2009

FERNANDINA BEACH, Fla., Jan. 13 /PRNewswire/ -- Zassi Medical Evolutions(R), a privately held organization with a 12 year history of innovation and development, today announced the launch of e-Zassi(TM) an online community dedicated to delivering powerful efficiencies to the medical device industry by streamlining diligence, collaboration and discovery of new medical technologies and industry participants with an exclusive array of intelligent Web-based applications.

In development for several years, e-Zassi.com has been designed to extract critical technical and business related traits and attributes from technologies, organizations and individuals within the medical device-specific community. This "business DNA" can then be leveraged to increase search/match relevancy and materially enhance success rates and lower costs.

e-Zassi's proprietary Deep DNA (Device Network Attributes) profiling technology captures in-depth and highly relevant search criteria on the proficiencies, preferences and targeted areas for development of individuals and organizations. The company believes that allowing members to leverage these vital attributes to enable collaboration in the medical device sector will lower costs and create efficiencies; as these capabilities are not typically identified or utilized by existing broad, traditional business networks or search engines.

Available by subscription, e-Zassi members will have 24/7 access to a variety of modules including the world's first Innovation Assessment software platform. This platform allows members to deeply analyze and profile medical technologies via a simple to use question and answer process. Impressively, the program utilizes no confidential information to generate powerful development and commercially related outputs that are critical to activities such as:

    -- Technology Transfer
    -- Business Development,
    -- Market and Commercial Analysis
    -- Due Diligence
    -- Intellectual Property and Patent Development
    -- Product Development and Financial Planning

The company recognizes the value provided by the ability to gain insights earlier in the innovation, development and financing decision process of a new product or technology. Knowledge in areas such as its clinical, regulatory, reimbursement, market, manufacturing, distribution and sales requirements are critical in helping to ensure successful development and commercialization. The e-Zassi system delivers this decision support knowledge in minutes providing exceptional value to innovators, device manufacturers, service providers, venture capital firms, researchers and healthcare providers as they diligence, develop, fund or provide services for medical technologies.

"The $250B global medical device industry invests more than $40B annually in new product innovation and development alone. As such, it requires rapid decision making, comprehensive planning and increased efficiency in terms of technology due diligence, business networking and strategic partnering. As veterans from the medical device space ourselves, we know traditional connectivity methods such as conventions, magazine advertising, and even the use of broad, non-medical device online networking sites are not really cost effective and do not address the very specific technical and business requirements of our industry. We knew it was time to combine the latest in Cloud Computing technology with our powerful new DNA based assessment and collaboration software platforms to create a vertical search engine dedicated to our specific device industry as existing general search engines are becoming flooded with too much noise," states Peter M. von Dyck, e-Zassi's Founder and Chief Executive Officer.

Special Charter Memberships are available now for a limited time. For more information regarding e-Zassi or to sign up to join the community please visit www.e-zassi.com or call (866) 474-6328.


'/>"/>
SOURCE Zassi Medical Evolutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MSU engineering team designs innovative medical device
2. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
3. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
4. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
5. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
6. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
7. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
8. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
9. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
10. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
11. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... 2017 , ... Accreditation Commission for Health Care (ACHC) is ... (HCAOA). This agreement allows HCAOA members to receive special pricing on ACHC’s Home ... University (AU) educational resources that help prepare HCAOA members for ACHC Accreditation. , ...
(Date:4/28/2017)... Clara, CA (PRWEB) , ... April 28, 2017 ... ... is pleased to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep ... user experience, since it streamlines the reporting process and provides a familiar interface ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, ... the GlycoMark test throughout the Northeast U.S. , GlycoMark is the only ... The GlycoMark test provides a clinically proven one- to two-week measure of hyperglycemic ...
(Date:4/28/2017)... ... 2017 , ... Ushio America proudly introduces the new ... solution for F32T8 fluorescent lamps on most instant-start and programmed-start electronic ballasts so ... lamps utilize the existing electronic ballast, saving labor and maintenance costs. It’s easy ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... --  ZappRx, Inc ., a digital health company focused on ... it closed $25 million in Series B funding led by ... Seattle that is part of a ... B round included participation from SR One , who ... (formerly Google Ventures). As part of the financing, ...
(Date:4/20/2017)... , April 20, 2017 Eyevensys, ... the first non-viral gene expression technology that enables the ... eye to address a wide range of ophthalmic diseases, ... and Healthcare products Regulatory Agency (MHRA) to advance its ... ...
(Date:4/19/2017)... - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that ... Conference 2017 at the Sheraton Hotel in Toronto, Ontario ... of the Company is scheduled to present on Tuesday, May 2 ... the Chairman of the Board, Tony Holler will also ... For more ...
Breaking Medicine Technology: